Stany Zjednoczone - angielski - NLM (National Library of Medicine)

sun pharmaceutical industries, inc - sulfamethoxazole (unii: je42381tnv) (sulfamethoxazole - unii:je42381tnv), trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - sulfamethoxazole 800 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of bactrim (sulfamethoxazole and trimethoprim) tablets and other antibacterial drugs, bactrim (sulfamethoxazole and trimethoprim) tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to empiric selection of therapy. urinary tract infections for the treatment of urinary tract infections due to susceptible strains of the following organisms: escherichia coli , klebsiella species, enterobacter species, morganella morganii , proteus mirabilis and proteus vulgaris . it is recommended that initial episodes of uncomplicated urinary tract infections be treated with a single effective antibacterial agent rather than the combination. acute otitis media for the treatment of acute otitis media in pediatric patients due to susceptible strains of streptococcus pneumoniae or haemophilus influenzae when in the judgment of the physician sulfamethoxazole and trimethoprim offers some advantage over the use of other antimicrobial agents. to date, there are limited data on the safety of repeated use of bactrim in pediatric patients under two years of age. bactrim is not indicated for prophylactic or prolonged administration in otitis media at any age. acute exacerbations of chronic bronchitis in adults for the treatment of acute exacerbations of chronic bronchitis due to susceptible strains of streptococcus pneumoniae or haemophilus influenzae when a physician deems that bactrim could offer some advantage over the use of a single antimicrobial agent. shigellosis for the treatment of enteritis caused by susceptible strains of shigella flexneri and shigella sonnei when antibacterial therapy is indicated. pneumocystis jirovecii pneumonia for the treatment of documented pneumocystis jirovecii pneumonia and for prophylaxis against p. jirovecii pneumonia in individuals who are immunosuppressed and considered to be at an increased risk of developing p. jirovecii pneumonia. traveler's diarrhea in adults for the treatment of traveler's diarrhea due to susceptible strains of enterotoxigenic e. coli . bactrim is contraindicated in the following situations: - a known hypersensitivity to trimethoprim or sulfonamides - history of drug-induced immune thrombocytopenia with use of trimethoprim and/or sulfonamides - documented megaloblastic anemia due to folate deficiency - pediatric patients less than 2 months of age - marked hepatic damage - severe renal insufficiency when renal function status cannot be monitored - concomitant administration with dofetilide (see precautions ).

Republika Południowej Afryki - angielski - South African Health Products Regulatory Authority (SAHPRA)

smith & nephew -

Australia - angielski - Department of Health (Therapeutic Goods Administration)

smith & nephew pty ltd - silver sulfadiazine - cream - flamazine cream is indicated for the prevention of infection in severe burns. other types of wounds, such as pressure sores and leg ulcers, may also benefit from the application of flamazine cream.

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

link pharmaceuticals ltd - dapsone 100mg - tablet - 100 mg - active: dapsone 100mg excipient: colloidal silicon dioxide magnesium stearate maize starch microcrystalline cellulose - dermatitis herpetiformis.

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

pacific pharmaceuticals limited (part of mylan) - dapsone 100mg (amount mg/tablet) - tablet - 100 mg - active: dapsone 100mg (amount mg/tablet) excipient: lactose monohydrate magnesium stearate microcrystalline cellulose sodium starch glycolate

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

link pharmaceuticals ltd - dapsone 25mg - tablet - 25 mg - active: dapsone 25mg excipient: colloidal silicon dioxide magnesium stearate maize starch microcrystalline cellulose - dermatitis herpetiformis.

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

amgen new zealand limited - pegfilgrastim 10 mg/ml;   - solution for injection - 6 mg/0.6ml - active: pegfilgrastim 10 mg/ml   excipient: acetic acid polysorbate 20 sodium hydroxide sorbitol water for injection - reduction in the duration of neutropenia, the incidence of febrile neutropenia and the incidence of infection as manifested by febrile neutropenia in patients treated with cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes).

Australia - angielski - Department of Health (Therapeutic Goods Administration)

smith & nephew pty ltd - silver sulfadiazine - cream - flamazine cream is indicated for the prevention of infection in severe burns. other types of wounds, such as pressure sores and leg ulcers, may also benefit from the application of flamazine cream.

Irlandia - angielski - HPRA (Health Products Regulatory Authority)

vetoquinol ireland limited - chlortetracycline; sulphanilamide - cutaneous spray, powder - 2.85, 50 gram/100gram - chlortetracycline, combinations - cattle, dogs, goats, horses, sheep - antibacterial

Kanada - angielski - Health Canada

aspen pharmacare canada inc. - trimethoprim; sulfamethoxazole - suspension - 8mg; 40mg - trimethoprim 8mg; sulfamethoxazole 40mg - sulfonamides